Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
Authors
Keywords
Dipeptidyl peptidase-4 inhibitors, Sitagliptin, Saxagliptin, Heart failure, Drug safety, Disproportionality, Spontaneous reporting system, FAERS
Journal
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Volume 26, Issue 5, Pages 380-386
Publisher
Elsevier BV
Online
2016-02-20
DOI
10.1016/j.numecd.2016.02.006

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.